Panel: EXHAUSTED SPEECH: THE LIMITS OF LANGUAGE AND REPRESENTATION IN THE FACE OF SUFFERING



203.6 - WEAKSTRENGTHS AND STRONGWEAKNESSES — SUBVERTING THE RESILIENCE IMPERATIVE IN THE FACE OF "UNPRODUCTIVE" SUFFERING

AUTHORS:
Bischoff S. (Independent Scholar ~ Berlin ~ Germany)
Text:
Contemporary theological and philosophical discourses on suffering are often "exhausted" by a pervasive resilience imperative, epitomized by the pop-cultural adaptation of Nietzsche's dictum: "What doesn't kill you makes you stronger". This form of speech has become a worn-out trope that forces every experience of precarity into a narrative of self-optimization, growth, or (spiritual) profit. However, such language fails and reaches its limits when confronted with concrete, "unproductive" suffering - experiences of dis_ability, trauma, or loss that leave nothing behind but "weakness" and cannot or do not want to be heroically reinterpreted or redemptively sacralized. Drawing on 2 Corinthians 12:1-10, this paper explores how the Apostle Paul reacts to the stigmatization of his "thorn in the flesh" - interpreted here as a permanent impairment / dis_ability. Rather than submitting to the binary logic of his opponents, who equate dis_ability with a lack of authority, Paul performs a subversive semantic shift. Utilizing Judith Butler's theory of resignification and performative repetition, the paper argues that Paul does not merely "overcome" weakness but destabilizes the very categories of "strong" and "weak". Here, neologisms such as "weakstrengths" and "strongweaknesses" come into play, serving as preliminary linguistic and subversive tools to unveil their discursive materiality, refusing forced harmonization or the pressure to transform weakness into a "hidden potential". Ultimately, the paper proposes that a theologian's responsibility in the face of suffering lies in refusing to solve the tension of suffering, allowing weakness to remain weakness while subverting the power-knowledge structures that devalue or stigmatize its existence.